Oral semaglutide versus subcutaneous liraglutide and placebo in type 2 diabetes (PIONEER 4): a randomised, double-blind, phase 3a trial Article

ESI Most Cited Paper Industry Collaboration International Collaboration

cited authors

  • Pratley, Richard; Amod, Aslam; Hoff, Soren Tetens; Kadowaki, Takashi; Lingvay, Ildiko; Nauck, Michael; Pedersen, Karen Boje; Saugstrup, Trine; Meier, Juris J.; PIONEER 4 Investigators

authors

Publication Date

  • July 6, 2019

webpage

published in

category

start page

  • 39

end page

  • 50

volume

  • 394

issue

  • 10192